Amdocs Earnings Estimate

DOX
 Stock
  

USD 83.34  0.01  0.012%   

Many public companies, such as Amdocs, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Amdocs' earnings estimates, investors can diagnose different trends across Amdocs' analyst sentiment over time as well as compare current estimates against different timeframes.
Amdocs is projected to generate 4.78 in earnings per share on the 31st of December 2022. Amdocs earnings estimates module stress-tests analyst consensus about projected Amdocs Limited EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Continue to Investing Opportunities.
  
Refresh
Gross Profit is likely to drop to about 1.7 B in 2022. Profit Margin is likely to drop to 0.17 in 2022
Share

Amdocs Earnings Estimation Breakdown

Calculation of earning per share of Amdocs Limited is based on official Zacks consensus of 2 analysts regarding Amdocs future annual earnings. Given the historical accuracy of 96.68%, the future earnings per share of Amdocs is estimated to be 4.78 with the lowest and highest values of 4.73 and 4.89, respectively. Please note that this consensus of annual earnings estimates for Amdocs Limited is an estimate of EPS before non-recurring items and including employee stock options expenses
  Current EPS 5.32
4.73
Lowest
Expected EPS 4.78
4.89
Highest

Amdocs Earnings Projection Consensus

Suppose the current estimates of Amdocs' value are higher than the current market price of the Amdocs stock. In this case, investors may conclude that Amdocs is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Amdocs' stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyCurrent EPSEPS Estimate for 31st of December 2022

2

96.68%

5.32

4.78

Amdocs Earnings History

Earnings estimate consensus by Amdocs Limited analysts from Wall Street is used by the market to judge Amdocs' stock performance. The investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Amdocs' upcoming profit reports and earnings-per-share forecasts but also compare them to our different valuation methods.

Amdocs Quarterly Earnings Before Interest Taxes and Depreciation Amortization EBITDA

213.85 Million

Share
Price to Earnings Ratio is likely to rise to 18.95 in 2022, whereas Accumulated Retained Earnings Deficit are likely to drop slightly above 5.9 B in 2022. Amdocs Weighted Average Shares is fairly stable at the moment as compared to the past year. Amdocs reported Weighted Average Shares of 118.38 Million in 2021. Weighted Average Shares Diluted is likely to rise to about 148.1 M in 2022, whereas Issuance Purchase of Equity Shares is likely to drop (573.8 M) in 2022.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Amdocs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Amdocs in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
81.6583.3184.97
Details
Intrinsic
Valuation
LowReal ValueHigh
75.0192.8894.54
Details
Naive
Forecast
LowNext ValueHigh
86.5988.2589.91
Details
3 Analysts
Consensus
LowTarget PriceHigh
78.0088.2099.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Amdocs. Your research has to be compared to or analyzed against Amdocs' peers to derive any actionable benefits. When done correctly, Amdocs' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Amdocs Limited.
Note that many institutional investors and large investment bankers can move markets due to the volume of Amdocs assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards Amdocs. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving Amdocs stock price in the short term.

Amdocs Earnings per Share Projection vs Actual

Actual Earning per Share of Amdocs refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Amdocs Limited predict the company's earnings will be in the future. The higher the earnings per share of Amdocs, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Amdocs Estimated Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Amdocs, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Amdocs should always be considered in relation to other companies to make a more educated investment decision.

Amdocs Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Amdocs' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-05-11
2022-03-311.251.540.2923 
2022-02-01
2021-12-311.181.20.02
2021-11-02
2021-09-301.17671.16-0.0167
2021-08-04
2021-06-301.18031.350.169714 
2021-05-12
2021-03-311.13181.13-0.0018
2021-02-02
2020-12-311.13611.160.0239
2020-11-10
2020-09-301.1851.230.045
2020-08-05
2020-06-301.04941.070.0206
2020-05-07
2020-03-311.0631.080.017
2020-02-04
2019-12-311.05331.060.0067
2019-11-12
2019-09-301.07681.080.0032
2019-08-07
2019-06-301.11281.190.0772
2019-05-14
2019-03-311.03141.060.0286
2019-02-05
2018-12-310.9910.98-0.011
2018-11-08
2018-09-300.98470.990.0053
2018-07-31
2018-06-301.03311.03-0.0031
2018-05-10
2018-03-310.95330.95-0.0033
2018-01-30
2017-12-310.97151.060.0885
2017-11-08
2017-09-300.9470.94-0.007
2017-08-02
2017-06-300.961.020.06
2017-05-09
2017-03-310.93020.940.0098
2017-02-01
2016-12-310.90490.9-0.0049
2016-11-08
2016-09-300.88870.890.0013
2016-07-26
2016-06-300.87220.90.0278
2016-05-04
2016-03-310.87350.920.0465
2016-02-02
2015-12-310.85510.860.0049
2015-11-10
2015-09-300.820.840.02
2015-07-29
2015-06-300.820.840.02
2015-04-29
2015-03-310.820.820
2015-01-27
2014-12-310.810.880.07
2014-11-04
2014-09-300.790.78-0.01
2014-07-29
2014-06-300.790.810.02
2014-04-30
2014-03-310.780.810.03
2014-01-29
2013-12-310.750.760.01
2013-11-05
2013-09-300.640.63-0.01
2013-07-31
2013-06-300.730.830.113 
2013-04-30
2013-03-310.720.730.01
2013-01-30
2012-12-310.710.730.02
2012-11-06
2012-09-300.70.70
2012-08-01
2012-06-300.670.70.03
2012-05-01
2012-03-310.640.670.03
2012-02-01
2011-12-310.640.640
2011-11-08
2011-09-300.620.620
2011-07-27
2011-06-300.60.610.01
2011-04-28
2011-03-310.570.580.01
2011-01-25
2010-12-310.540.52-0.02
2010-11-03
2010-09-300.590.620.03
2010-07-21
2010-06-300.570.580.01
2010-04-22
2010-03-310.550.560.01
2010-01-20
2009-12-310.530.550.02
2009-11-04
2009-09-300.490.530.04
2009-07-22
2009-06-300.480.530.0510 
2009-04-22
2009-03-310.490.50.01
2009-01-21
2008-12-310.550.550
2008-11-05
2008-09-300.620.54-0.0812 
2008-07-23
2008-06-300.60.610.01
2008-04-17
2008-03-310.570.580.01
2008-01-22
2007-12-310.560.560
2007-10-31
2007-09-300.540.540
2007-07-18
2007-06-300.510.540.03
2007-04-26
2007-03-310.50.520.02
2007-01-17
2006-12-310.50.530.03
2006-11-01
2006-09-300.490.50.01
2006-07-19
2006-06-300.460.490.03
2006-04-26
2006-03-310.420.440.02
2006-01-18
2005-12-310.40.420.02
2005-11-09
2005-09-300.380.390.01
2005-07-20
2005-06-300.360.370.01
2005-04-20
2005-03-310.350.350
2005-01-19
2004-12-310.310.340.03
2004-11-03
2004-09-300.30.310.01
2004-07-21
2004-06-300.30.30
2004-04-21
2004-03-310.270.290.02
2004-01-21
2003-12-310.240.260.02
2003-11-05
2003-09-300.230.230
2003-07-23
2003-06-300.230.230
2003-04-15
2003-03-310.190.220.0315 
2003-01-22
2002-12-310.180.20.0211 
2002-11-06
2002-09-300.170.190.0211 
2002-07-25
2002-06-300.20.20
2002-04-23
2002-03-310.360.370.01
2002-01-22
2001-12-310.350.360.01
2001-11-06
2001-09-300.340.350.01
2001-07-24
2001-06-300.320.330.01
2001-04-23
2001-03-310.290.30.01
2001-01-23
2000-12-310.260.270.01
2000-11-08
2000-09-300.190.250.0631 
2000-07-18
2000-06-300.220.230.01
2000-04-18
2000-03-310.190.210.0210 
2000-01-25
1999-12-310.150.180.0320 
1999-11-09
1999-09-300.140.150.01
1999-07-27
1999-06-300.120.130.01
1999-04-27
1999-03-310.10.120.0220 
1999-01-25
1998-12-310.090.10.0111 
1998-11-11
1998-09-300.050.060.0120 
1998-09-28
1998-06-300.040.040

About Amdocs Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Amdocs earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Amdocs estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Amdocs fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for 2022
Accumulated Retained Earnings Deficit6.7 B5.9 B
Earning Before Interest and Taxes EBIT948.9 M802.5 M
Earnings per Basic Share 6.16  4.98 
Earnings per Diluted Share 6.12  4.95 
Price to Earnings Ratio 16.24  18.95 
Earnings Before Interest Taxes and Depreciation Amortization EBITDA1.2 BB
Earnings before Tax936.5 M792.9 M
Amdocs Limited, through its subsidiaries, provides software and services worldwide. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri. Amdocs operates under SoftwareInfrastructure classification in the United States and is traded on NASDAQ Exchange. It employs 29000 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amdocs without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Amdocs Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs Limited to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Investing Opportunities. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.41
Market Capitalization
10.2 B
Quarterly Revenue Growth YOY
0.092
Return On Assets
0.0601
Return On Equity
0.16
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.